Ligilactobacillus salivarius LS01
Ligilactobacillus salivarius LS01 (also registered as DSM 22775) has been studied in the context of atopic dermatitis, a chronic inflammatory skin condition, in several randomized, placebo-controlled trials in adults and children. Human trial evidence also extends to pediatric asthma management, where LS01 was evaluated in combination with Bifidobacterium breve B632. In vitro work has examined immunomodulatory activity involving NF-κB and COX-2 pathways in airway inflammation models. Meta-analyses examining probiotics in adult atopic dermatitis provide broader context, though they are not specific to this strain alone. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 9 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 6 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
9 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 35670101 →The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis· Journal of Dermatological Treatment · 2022
-
[2]
PMID 25291124 →Preliminary Results on Clinical Effects of Probiotic Lactobacillus salivarius LS01 in Children Affected by Atopic Dermatitis· Journal of Clinical Gastroenterology · 2014
-
[3]
PMID 25291127 →Treatment of Atopic Dermatitis Eczema With a High Concentration of Lactobacillus salivarius LS01 Associated With an Innovative Gelling Complex· Journal of Clinical Gastroenterology · 2014
-
[4]
PMID 22955359 →Changing of Fecal Flora and Clinical Effect of L. salivarius LS01 in Adults With Atopic Dermatitis· Journal of Clinical Gastroenterology · 2012
-
[5]
PMID 22230409 →Effects of Lactobacillus Salivarius LS01 (DSM 22775) Treatment on Adult Atopic Dermatitis: A Randomized Placebo-Controlled Study· International Journal of Immunopathology and Pharmacology · 2011